TATX-27

N/A

Report date: 2025/10/27 17:15:36

Base Information

Drug NameTATX-27
Drug Alias NameTATX-27
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionLymphocyte differentiation antigen CD38 modulators
TargetsLymphocyte differentiation antigen CD38
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTalem Therapeutics LLC
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A